Evidence map›Paper›PMID 18976673›Full record

ArticleLife sciences2008

Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation.

Xiang-Yang Zhu, Elena Daghini, Alejandro R Chade, Ronit Lavi, Claudio Napoli, Amir Lerman, Lilach O Lerman

Abstract read
In one paragraph

Article in Life sciences, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Etanercept as a TNF-alpha inhibitor depresses experimental retinal neovascularization.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. The many roles of statins in ischemic stroke.Current neuropharmacology · 2014
    Article
  17. Simvastatin reduces VEGF and NO levels in acute stages of experimental traumatic brain injury.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2013
    Article
  18. Review
  19. Review
  20. The effect of atorvastatin on survival of rat ischemic flap.The Kaohsiung journal of medical sciences · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Xiang-Yang ZhuDepartment of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, United States.
Elena Daghini
Alejandro R Chade
Ronit Lavi
Claudio Napoli
Amir Lerman
Lilach O Lerman
Mayo Clinic · USUniversity of Naples Federico II · IT

Funding

Tissue Oxygenation in Human Renovascular HypertensionP01HL085307 · NHLBI · MAYO CLINIC ROCHESTER · PI ROMERO, JUAN C · 2007 to 2011
$10.4M
CT imaging for the assessment of kidney injury distal to renal artery stenosisR01DK073608 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2006 to 2015
$3.1M
CT Evaluation of the Myocardial Effects of Risk FactorsR01HL077131 · NHLBI · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2004 to 2013
$2.8M
Autologous Progenitor Cells Delivery in Renovascular DiseaseR21DK077013 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2008 to 2009
$416k
NHLBI NIH HHS HL77131NHLBI NIH HHS P01 HL085307NHLBI NIH HHS P01HL085307NHLBI NIH HHS R01 HL077131NIDDK NIH HHS DK-73608NIDDK NIH HHS DK77013NIDDK NIH HHS R01 DK073608NIDDK NIH HHS R21 DK077013
6 · The paper itself

Abstract

aimsStudies have shown that some of statin's pleiotropic effects were achieved by either promotion or inhibition of angiogenesis, depending on the underlying disease. This study tested the hypothesis that the angiogenic potential of simvastatin is related to the microenvironmental conditions. MAIN

methodsHuman umbilical vein endothelial cells (HUVEC) were studied after exposure to hypoxia or the inflammatory factors tumor necrosis factor (TNF)-alpha, with or without co-incubation with simvastatin (1 micromol/L) and mevalonate. HUVEC angiogenesis was evaluated by tube formation, migration, and proliferation assays. Hypoxia inducible factor (HIF)-1alpha, vascular endothelial growth factor (VEGF), Akt, endothelium nitric oxide synthase (e-NOS), and oxidative stress were evaluated. KEY

findingsHUVEC angiogenesis increased during hypoxia (tube length 14.7+/-0.5 vs. 7.8+/-0.6 mm, p<0.05) and further enhanced by simvastatin (19.3+/-1.1 mm, p<0.05 vs. hypoxia alone), which downregulated the expression of the HIF-1 inhibitor PHD2 and upregulated HIF-1alpha, VEGF, and Akt, without changing oxidative stress or eNOS. Incubation with TNF-alpha promoted HUVEC angiogenesis (7.4+/-0.2 vs. 6.5+/-0.2 mm, p<0.05) with increased oxidative stress. However, simvastatin inhibited this promotion (2.5+/-0.3 mm, p<0.001 vs. TNF-alpha alone) by decreasing oxidative stress, VEGF, Akt, and eNOS. SIGNIFICANCE: We conclude that at the same dosage, simvastatin can either promote or inhibit angiogenesis, possibly by activating upstream regulators of HIF-1alpha in hypoxia, but conversely interfering with angiogenic signaling downstream to inflammation. These opposing angiogenic effects should be considered in the therapeutic strategies with statins.

Indexed as

Neovascularization, PathologicCell HypoxiaCell LineEndothelial CellsEndothelium, VascularHumansHypolipidemic AgentsHypoxiaHypoxia-Inducible Factor 1, alpha SubunitInflammationModels, BiologicalOxidative StressSimvastatinTumor Necrosis Factor-alphaHypolipidemic AgentsHypoxia-Inducible Factor 1, alpha SubunitSimvastatinTumor Necrosis Factor-alpha

Identifiers

PMID18976673
PMCPMC2596882
OpenAlexW2062235476

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.